Searched for
COMBINATION INHALERS
Can a cough reveal lung disease? Swaasa AI uses cough sound analysis to screen respiratory disordersAI-powered platform Swaasa is using cough sound analysis through smartphones to help screen respiratory diseases such as COPD, asthma and p...07 May, 2026, 05.30 PM IST- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...06 May, 2026, 11.19 PM IST
- Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in IndiaAstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca w...11 Mar, 2024, 05.39 PM IST
- Cipla hits 15% upper circuit as USFDA gives final approval to Albuterol Inhalation AerosolFollowing the development, the scrip hit its 15 per cent upper circuit limit at Rs 589.95.09 Apr, 2020, 03.47 PM IST
- Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation AerosolIn a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...09 Apr, 2020, 01.14 PM IST
- Glenmark Pharma rallies on Germany marketing nodThe drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.10 Sep, 2018, 10.31 AM IST
- Glenmark Pharma launches generic version of asthma drug in DenmarkThe product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.16 May, 2018, 10.57 AM IST
- World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.02 May, 2017, 12.09 PM IST
- Cipla’s inhalable insulin fails to get approval for trials on Indian patientsCipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was ...06 Dec, 2016, 02.00 AM IST
- Glenmark Pharmaceuticals inks pact with Celon for generic Seretide AccuhalerAs per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries23 Oct, 2015, 03.12 PM IST
- Cipla launches combination inhalers in Germany and Sweeden; stocks touch all time high, may trigger reratingThe maiden launch increases the possibility and visibility of subsequent launches of the company’s inhalers in other countries.04 Sep, 2014, 03.32 AM IST
- Brokerages raise Cipla's target price post inhaler launchAnalysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.02 Sep, 2014, 11.44 AM IST
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...04 Jul, 2012, 05.05 AM IST
- FDA approves Merck's new lung drug DuleraMerck & Co Inc's new two-in-one respiratory drug Dulera has been approved by the US Food and Drug Administration, the US company said on Th...24 Jun, 2010, 06.47 PM IST
- Piramal buys US pharma co Minrad for $40 mPiramal Healthcare (PHL) has acquired US-based pharmaceutical company Minrad International for $40 million (Rs 188 crore).24 Dec, 2008, 12.40 AM IST
- Piramal signs deal to acquire Minrad InternationalPiramal Healthcare Ltd and Minrad International have jointly signed a definitive merger agreement for Piramal to acquire Minrad.23 Dec, 2008, 11.00 AM IST
- Ranbaxy launches new drug for asthmaRanbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...12 Sep, 2006, 02.20 PM IST
Load More
